ArticleMolecules (Basel, Switzerland)2026
A Controlled Study of Physics-Informed Auxiliary Supervision and Scalar Triplet Attention in Equivariant Molecular Force Fields.
Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Machine-learned molecular force fields require many-body geometry, but obtaining it through Clebsch-Gordan tensor products is computationally expensive. For a strong no-Clebsch-Gordan backbone such as GotenNet, we ask whether the limitation in handling three-body geometry is one of representational capacity or one of training supervision, and separate the two factors with three controlled probes on a single-seed, paper-aligned rMD17 aspirin split. (i) While frame projection of tensor features is comparable to scalar cos-angle triplet cross-attention (SCTA) at pilot scale, algebraically its diagonal scalar collapses to a frame-independent inner product and the remaining channel is parity-odd, making SCTA's cos-angle input the principled O(3) scalar choice. (ii) SCTA matches GotenNet's converged force accuracy within ∼0.4% without independent gain, indicating that three-body representational capacity is not the binding constraint. (iii) A graph-level auxiliary loss on bond-angle and dihedral statistics gives the best force mean absolute error (MAE; 0.1280 vs. 0.1303 kcal/mol/Å) and reduces epochs-to-validation-target by 26-55%. Cross-molecule probes do not extend this finding; a paired salicylic acid comparison shows a directional degradation that, under a configuration-level paired block bootstrap, is significant and opposite in sign to the aspirin effect. Across three random seeds, the auxiliary force-MAE gain is small and seed-dependent but consistently reduces seed-to-seed variance and accelerates convergence, indicating that low-cost three-body supervision can be a more effective lever than added three-body capacity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.